← Back to headlines
ImmunityBio Gains on New Anktiva Indication in NCCN Guidelines
ImmunityBio's stock has seen gains following the inclusion of a new Anktiva indication in the National Comprehensive Cancer Network (NCCN) guidelines.
17 Mar, 12:07 — 17 Mar, 12:07
Sources
Showing 1 of 1 sources
Related Stories
Zaanstad's Unsuccessful Attempt to Dismantle Criminal Window Cleaner Empire
just now
Kriza na Bliskom istoku već pogađa turizam u BiH: Otkazane brojne posjete
just now
Middle East Crisis Impacts BiH Tourism, Leading to Cancellations
just now
IDF Soldier Severely Injured in Gaza Operational Accident
just now